GB0000079D0 - Novel antidiuretic agents - Google Patents

Novel antidiuretic agents

Info

Publication number
GB0000079D0
GB0000079D0 GBGB0000079.4A GB0000079A GB0000079D0 GB 0000079 D0 GB0000079 D0 GB 0000079D0 GB 0000079 A GB0000079 A GB 0000079A GB 0000079 D0 GB0000079 D0 GB 0000079D0
Authority
GB
United Kingdom
Prior art keywords
novel
antidiuretic agents
antidiuretic
agents
novel antidiuretic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0000079.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring BV
Original Assignee
Ferring BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring BV filed Critical Ferring BV
Priority to GBGB0000079.4A priority Critical patent/GB0000079D0/en
Publication of GB0000079D0 publication Critical patent/GB0000079D0/en
Priority to MXPA02006546A priority patent/MXPA02006546A/es
Priority to CA2396277A priority patent/CA2396277C/en
Priority to KR1020027006382A priority patent/KR100605466B1/ko
Priority to PCT/GB2001/000023 priority patent/WO2001049682A1/en
Priority to EEP200200367A priority patent/EE200200367A/xx
Priority to CZ20022305A priority patent/CZ303444B6/cs
Priority to BRPI0107414-8A priority patent/BR0107414B1/pt
Priority to PT01900169T priority patent/PT1248784E/pt
Priority to AU23846/01A priority patent/AU777538B2/en
Priority to IL14952801A priority patent/IL149528A0/xx
Priority to SI200130766T priority patent/SI1248784T1/sl
Priority to CNB018031323A priority patent/CN1183129C/zh
Priority to DE60129298T priority patent/DE60129298T2/de
Priority to NZ518803A priority patent/NZ518803A/xx
Priority to HU0203917A priority patent/HU229937B1/hu
Priority to PL355808A priority patent/PL211341B1/pl
Priority to DK01900169T priority patent/DK1248784T3/da
Priority to SK911-2002A priority patent/SK287005B6/sk
Priority to UY26521A priority patent/UY26521A1/es
Priority to EP01900169A priority patent/EP1248784B1/en
Priority to JP2001550222A priority patent/JP3869723B2/ja
Priority to MYPI20010027A priority patent/MY140467A/en
Priority to HK02108525.5A priority patent/HK1046910B/en
Priority to ARP010100035A priority patent/AR035327A1/es
Priority to ES01900169T priority patent/ES2288923T3/es
Priority to HR20020481A priority patent/HRP20020481B1/xx
Priority to AT01900169T priority patent/ATE366730T1/de
Priority to RU2002120798/04A priority patent/RU2259367C2/ru
Priority to US10/130,749 priority patent/US7074781B2/en
Priority to UA2002075517A priority patent/UA73152C2/uk
Priority to NO20023137A priority patent/NO322571B1/no
Priority to ZA200205180A priority patent/ZA200205180B/en
Priority to JP2005366100A priority patent/JP3813629B2/ja
Priority to US11/370,861 priority patent/US7560454B2/en
Priority to CY20071101261T priority patent/CY1108034T1/el
Priority to US12/213,651 priority patent/US20080261951A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0000079.4A 2000-01-05 2000-01-05 Novel antidiuretic agents Ceased GB0000079D0 (en)

Priority Applications (37)

Application Number Priority Date Filing Date Title
GBGB0000079.4A GB0000079D0 (en) 2000-01-05 2000-01-05 Novel antidiuretic agents
US10/130,749 US7074781B2 (en) 2000-01-05 2001-01-04 Condensed azepines as vasopressin agonists
SK911-2002A SK287005B6 (sk) 2000-01-05 2001-01-04 Kondenzované azepíny ako vazopresínové agonisty, ich použitie a farmaceutický prostriedok s ich obsahom
UY26521A UY26521A1 (es) 2000-01-05 2001-01-04 Nuevos agentes antidiuréticos
KR1020027006382A KR100605466B1 (ko) 2000-01-05 2001-01-04 바소프레신 작용제로서의 축합 아제핀
PCT/GB2001/000023 WO2001049682A1 (en) 2000-01-05 2001-01-04 Condensed azepines as vasopressin agonists
EEP200200367A EE200200367A (et) 2000-01-05 2001-01-04 Kondenseeritud asepiinid kui vasopressiini agonistid
JP2001550222A JP3869723B2 (ja) 2000-01-05 2001-01-04 バソプレッシン・アゴニストとしての縮合アゼピン
BRPI0107414-8A BR0107414B1 (pt) 2000-01-05 2001-01-04 Azepinas condensadas como agonistas de vasopressina, composição farmacêutica e uso dos referidos compostos
PT01900169T PT1248784E (pt) 2000-01-05 2001-01-04 Azepinas condençados como agonistas de vasopressina
AU23846/01A AU777538B2 (en) 2000-01-05 2001-01-04 Condensed azepines as vasopressin agonists
IL14952801A IL149528A0 (en) 2000-01-05 2001-01-04 Condensed azepines as vasopressin agonists
SI200130766T SI1248784T1 (sl) 2000-01-05 2001-01-04 Kondenzirani azepini kot agonisti vazopresina
CNB018031323A CN1183129C (zh) 2000-01-05 2001-01-04 作为加压素激动剂的稠合氮杂�
DE60129298T DE60129298T2 (de) 2000-01-05 2001-01-04 Kondensierte Azepine als Vasopressinagonisten
NZ518803A NZ518803A (en) 2000-01-05 2001-01-04 Condensed azepines as vasopressin agonists
HU0203917A HU229937B1 (hu) 2000-01-05 2001-01-04 Kondenzált azepinek mint vazopresszin agonisták, a vegyületek vagy ezek gyógyászatilag elfogadható sóinak alkalmazása gyógyszer-készítmény komponenseként vagy ennek elõállítására és a hatóanyagot tartalmazó gyógyszerkészítmény
PL355808A PL211341B1 (pl) 2000-01-05 2001-01-04 Skondensowane azepiny, zawierające je kompozycje farmaceutyczne i ich zastosowanie
DK01900169T DK1248784T3 (da) 2000-01-05 2001-01-04 Kondenserede azepiner som vasopressinagonister
MXPA02006546A MXPA02006546A (es) 2000-01-05 2001-01-04 Azepinas condensadas como agonistas de vasopressin.
EP01900169A EP1248784B1 (en) 2000-01-05 2001-01-04 Condensed azepines as vasopressin agonists
CA2396277A CA2396277C (en) 2000-01-05 2001-01-04 Condensed azepines as vasopressin agonists
CZ20022305A CZ303444B6 (cs) 2000-01-05 2001-01-04 Kondenzované azepiny jako vazopresinoví agonisté
MYPI20010027A MY140467A (en) 2000-01-05 2001-01-04 Condensed azepines as vasopressin agonists
HK02108525.5A HK1046910B (en) 2000-01-05 2001-01-04 Condensed azepines as vasopressin agonists
ARP010100035A AR035327A1 (es) 2000-01-05 2001-01-04 Agonistas no peptidicos de la vasopresina, selectivos para los receptores del subtipo v2; uso de dichos compuestos en la preparacion de composiciones farmaceuticas utilizables en el tratamiento de enfermedades del hombre, caracterizadas por poliuria; dichas composiciones y metodos para el tratamient
ES01900169T ES2288923T3 (es) 2000-01-05 2001-01-04 Azepinas condensadas como agonistas de la vasopresina.
HR20020481A HRP20020481B1 (hr) 2000-01-05 2001-01-04 Kondenzirani azepini kao agonisti vazopresina
AT01900169T ATE366730T1 (de) 2000-01-05 2001-01-04 Kondensierte azepine als vasopressinantagonisten
RU2002120798/04A RU2259367C2 (ru) 2000-01-05 2001-01-04 Конденсированные азепины, фармацевтическая композиция, содержащая их, способ лечения с использованием указанной композиции
UA2002075517A UA73152C2 (en) 2000-01-05 2001-04-01 Condensed azepins as agonists of vasopressin
NO20023137A NO322571B1 (no) 2000-01-05 2002-06-27 Kondenserte azepiner som vasopressinagonister
ZA200205180A ZA200205180B (en) 2000-01-05 2002-06-27 Condensed azepines as vasopressin agonists.
JP2005366100A JP3813629B2 (ja) 2000-01-05 2005-12-20 バソプレッシン・アゴニストとしての縮合アゼピン
US11/370,861 US7560454B2 (en) 2000-01-05 2006-03-09 Condensed azepines as vasopressin agonists
CY20071101261T CY1108034T1 (el) 2000-01-05 2007-10-04 Συμπυκνωμeνες αζεπiνες ως αγωνιστeς βαζοπρεσσiνης
US12/213,651 US20080261951A1 (en) 2000-01-05 2008-06-23 Condensed azepines as vasopressin agonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0000079.4A GB0000079D0 (en) 2000-01-05 2000-01-05 Novel antidiuretic agents

Publications (1)

Publication Number Publication Date
GB0000079D0 true GB0000079D0 (en) 2000-02-23

Family

ID=9883168

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0000079.4A Ceased GB0000079D0 (en) 2000-01-05 2000-01-05 Novel antidiuretic agents

Country Status (34)

Country Link
US (3) US7074781B2 (https=)
EP (1) EP1248784B1 (https=)
JP (2) JP3869723B2 (https=)
KR (1) KR100605466B1 (https=)
CN (1) CN1183129C (https=)
AR (1) AR035327A1 (https=)
AT (1) ATE366730T1 (https=)
AU (1) AU777538B2 (https=)
BR (1) BR0107414B1 (https=)
CA (1) CA2396277C (https=)
CY (1) CY1108034T1 (https=)
CZ (1) CZ303444B6 (https=)
DE (1) DE60129298T2 (https=)
DK (1) DK1248784T3 (https=)
EE (1) EE200200367A (https=)
ES (1) ES2288923T3 (https=)
GB (1) GB0000079D0 (https=)
HK (1) HK1046910B (https=)
HR (1) HRP20020481B1 (https=)
HU (1) HU229937B1 (https=)
IL (1) IL149528A0 (https=)
MX (1) MXPA02006546A (https=)
MY (1) MY140467A (https=)
NO (1) NO322571B1 (https=)
NZ (1) NZ518803A (https=)
PL (1) PL211341B1 (https=)
PT (1) PT1248784E (https=)
RU (1) RU2259367C2 (https=)
SI (1) SI1248784T1 (https=)
SK (1) SK287005B6 (https=)
UA (1) UA73152C2 (https=)
UY (1) UY26521A1 (https=)
WO (1) WO2001049682A1 (https=)
ZA (1) ZA200205180B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6234714B1 (en) 1995-12-08 2001-05-22 Nigel Chattey Pier and wharf structures having means for directly transferring cargo between two vessels or between a vessel and railcars

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7138393B2 (en) 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
GB0000079D0 (en) * 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
ATE329899T1 (de) * 2000-03-27 2006-07-15 Applied Research Systems Pharmazeutisch wirksame pyrrolidin-derivate als bax-inhibitoren
AU2001256209B2 (en) * 2000-03-27 2006-02-16 Merck Serono Sa Pharmaceutically active pyrrolidine derivatives
GB0015601D0 (en) * 2000-06-26 2000-08-16 Ferring Bv Novel antidiuretic agents
GB0115515D0 (en) * 2001-06-25 2001-08-15 Ferring Bv Oxytocin agonisys
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
EP1619185B1 (en) 2003-04-28 2011-06-15 Astellas Pharma Inc. 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivative or salt thereof
DK1530967T3 (da) * 2003-11-13 2006-07-03 Ferring Bv Blisterpakning og dertil hörende fast dosisform
WO2006054560A1 (ja) * 2004-11-17 2006-05-26 Kissei Pharmaceutical Co., Ltd. 芳香族アミド誘導体、それを含有する医薬組成物およびそれらの医薬用途
WO2006104008A1 (ja) * 2005-03-25 2006-10-05 Kissei Pharmaceutical Co., Ltd. ウレア誘導体、それを含有する医薬組成物およびそれらの医薬用途
WO2007052517A1 (ja) * 2005-10-31 2007-05-10 Sumitomo Chemical Company, Limited ヒドロキシ－２－ピロリジンカルボキシアミド化合物の製法
TW200820976A (en) * 2006-09-25 2008-05-16 Kissei Pharmaceutical 1,4-benzodiazepine derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes
US9096546B2 (en) * 2007-05-10 2015-08-04 Albany Molecular Research, Inc. Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
JP5451613B2 (ja) 2007-08-06 2014-03-26 アラーガン、インコーポレイテッド デスモプレシン薬物送達のための方法及びデバイス
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
NO3085381T3 (https=) * 2008-05-21 2018-09-15
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
GB201005623D0 (en) * 2010-04-01 2010-05-19 Vantia Ltd New polymorph
GB201105537D0 (en) * 2011-03-31 2011-05-18 Vantia Ltd New process
WO2020154581A1 (en) 2019-01-24 2020-07-30 Assia Chemical Industries Ltd Solid state forms of fedovapagon-salicyclic acid co-crystal

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3960886A (en) 1968-07-03 1976-06-01 Sterling Drug Inc. Substituted N-arylanilines
CH599752A5 (https=) 1973-04-18 1978-05-31 Ciba Geigy Ag
CA1047490A (en) 1973-04-18 1979-01-30 Friedrich Karrer Ethers
DE2355454A1 (de) 1973-11-07 1976-10-07 Paul Geisslinger Lochmaschine
CA1265798A (en) 1984-12-10 1990-02-13 Motoo Mutsukado 3(2h)pyridazinone, process for its preparation and anti-allergic agent containing it
DK0450097T3 (da) 1989-10-20 1996-05-20 Otsuka Pharma Co Ltd Benzoheterocykliske forbindelser
US5753677A (en) 1989-10-20 1998-05-19 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds
TW198715B (https=) * 1991-04-19 1993-01-21 Dtsuka Seiyaku Kk
JPH05320135A (ja) 1992-05-19 1993-12-03 Yamanouchi Pharmaceut Co Ltd テトラヒドロベンズアゼピン誘導体
WO1994004525A1 (en) 1992-08-20 1994-03-03 Otsuka Pharmaceutical Company, Limited Benzoheterocyclic compounds as oxytocin and vasopressin antagonists
TW270927B (https=) * 1992-10-16 1996-02-21 Otsuka Pharma Co Ltd
WO1994012476A1 (fr) * 1992-11-25 1994-06-09 Yamanouchi Pharmaceutical Co., Ltd. Derive de benzanilide
WO1994020473A1 (fr) * 1993-03-11 1994-09-15 Yamanouchi Pharmaceutical Co., Ltd. Compose avec action antagoniste de la vasopressine
GB9307527D0 (en) 1993-04-13 1993-06-02 Fujisawa Pharmaceutical Co New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
US5760031A (en) 1993-07-29 1998-06-02 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
US5968930A (en) 1993-07-29 1999-10-19 American Cyanamid Company Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
US5516774A (en) 1993-07-29 1996-05-14 American Cyanamid Company Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
US5843952A (en) 1993-07-29 1998-12-01 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
US6403577B1 (en) * 1993-11-17 2002-06-11 Eli Lilly And Company Hexamethyleneiminyl tachykinin receptor antagonists
FI1215U1 (fi) * 1993-12-03 1994-02-21 Valmet Paper Machinery Inc Anlaeggning i samband med styrningen av en vira
FR2716194B1 (fr) * 1994-02-14 1996-05-31 Sanofi Elf Dérivés de 3-acylamino-5-phényl-1,4-benzodiazépin-2-one polysubstitués, leur procédé de préparation et les compositions pharmaceutiques les contenant.
DE69514191T2 (de) * 1994-05-06 2000-08-17 Koninklijke Philips Electronics N.V., Eindhoven Mikrowellenübertragungssystem
ES2199251T3 (es) 1994-06-15 2004-02-16 Otsuka Pharmaceutical Company, Limited Derivados benzoheterociclicos utilizables como moduladores de vasopresina o de oxitocina.
JP2926335B2 (ja) 1997-06-13 1999-07-28 大塚製薬株式会社 医薬組成物
DE69826487T2 (de) * 1997-07-30 2005-12-01 Wyeth Trizyclische vasopressin-agonisten
BR9811559A (pt) * 1997-07-30 2000-09-12 American Home Prod Agonistas tricìclicos de vasopressina
JP2002527438A (ja) 1998-10-09 2002-08-27 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ４，５−ジヒドロ−イソオキサゾール誘導体及びそれらの製薬学的使用
GB2355454A (en) 1999-10-20 2001-04-25 Ferring Bv Antidiuretic agents
GB0000079D0 (en) * 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
GB0015601D0 (en) 2000-06-26 2000-08-16 Ferring Bv Novel antidiuretic agents
DE10033337A1 (de) 2000-07-08 2002-01-17 Boehringer Ingelheim Pharma Biphenylcarbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
GB0120051D0 (en) 2001-08-16 2001-10-10 Ferring Bv Oxytocin agonists
GB0224557D0 (en) 2002-10-22 2002-11-27 Glaxo Group Ltd Novel compounds
EP1449844A1 (en) 2003-02-14 2004-08-25 Ferring B.V. benzamide derivatives as oxytocin agonists and vasopressin antagonists
EP1627876A1 (en) 2004-08-20 2006-02-22 Ferring B.V. Heterocyclic condensed compounds useful as antidiuretic agents
US7341963B2 (en) * 2005-05-17 2008-03-11 Milliken & Company Non-woven material with barrier skin

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6234714B1 (en) 1995-12-08 2001-05-22 Nigel Chattey Pier and wharf structures having means for directly transferring cargo between two vessels or between a vessel and railcars

Also Published As

Publication number Publication date
HRP20020481B1 (hr) 2009-03-31
US20080261951A1 (en) 2008-10-23
EP1248784B1 (en) 2007-07-11
JP2006137767A (ja) 2006-06-01
HUP0203917A2 (hu) 2003-03-28
AR035327A1 (es) 2004-05-12
CN1183129C (zh) 2005-01-05
BR0107414A (pt) 2002-10-08
HU229937B1 (hu) 2015-01-28
AU2384601A (en) 2001-07-16
ES2288923T3 (es) 2008-02-01
AU777538B2 (en) 2004-10-21
CY1108034T1 (el) 2013-09-04
NZ518803A (en) 2003-03-28
SK9112002A3 (en) 2003-01-09
CZ303444B6 (cs) 2012-09-19
CN1392875A (zh) 2003-01-22
JP3869723B2 (ja) 2007-01-17
RU2259367C2 (ru) 2005-08-27
US20030087892A1 (en) 2003-05-08
CA2396277A1 (en) 2001-07-12
UY26521A1 (es) 2001-03-16
HK1046910A1 (en) 2003-01-30
DK1248784T3 (da) 2007-10-29
PL355808A1 (en) 2004-05-17
PT1248784E (pt) 2007-10-02
EE200200367A (et) 2003-12-15
UA73152C2 (en) 2005-06-15
US20060154916A1 (en) 2006-07-13
SK287005B6 (sk) 2009-09-07
CA2396277C (en) 2012-03-20
ATE366730T1 (de) 2007-08-15
IL149528A0 (en) 2002-11-10
JP2003519228A (ja) 2003-06-17
MXPA02006546A (es) 2002-12-09
NO20023137L (no) 2002-06-27
HK1046910B (en) 2007-08-31
PL211341B1 (pl) 2012-05-31
CZ20022305A3 (cs) 2002-10-16
NO20023137D0 (no) 2002-06-27
NO322571B1 (no) 2006-10-30
JP3813629B2 (ja) 2006-08-23
EP1248784A1 (en) 2002-10-16
KR100605466B1 (ko) 2006-07-28
DE60129298T2 (de) 2008-01-03
MY140467A (en) 2009-12-31
US7560454B2 (en) 2009-07-14
KR20020063191A (ko) 2002-08-01
HUP0203917A3 (en) 2004-07-28
RU2002120798A (ru) 2004-01-10
DE60129298D1 (de) 2007-08-23
WO2001049682A1 (en) 2001-07-12
US7074781B2 (en) 2006-07-11
BR0107414B1 (pt) 2014-09-16
SI1248784T1 (sl) 2007-12-31
ZA200205180B (en) 2004-02-05
HRP20020481A2 (en) 2004-08-31

Similar Documents

Publication Publication Date Title
IL150544A0 (en) Novel biarylcarboxamides
PL357210A1 (en) Novel use
AU8860401A (en) Novel guanidinobenzamides
GB0000079D0 (en) Novel antidiuretic agents
HUP0303043A3 (en) Rhinological agents
AU1217102A (en) Novel arylalkane-sulfonamides
IL153471A0 (en) Novel arylethene-sulfonamides
GB0012860D0 (en) Assay
GB0008784D0 (en) Assay
GB0027783D0 (en) Novel use
GB0005895D0 (en) Novel assay
GB0003902D0 (en) Assay
GB0005894D0 (en) Assay
GB0010960D0 (en) Assay
GB0001703D0 (en) Assay
GB0022992D0 (en) Novel vompounds
GB0003898D0 (en) Assay
GB0019524D0 (en) Novel use
GB9905034D0 (en) Antidiuretic agents
GB0029746D0 (en) Novel interaction
SI1259508T1 (en) Novel biarylcarboxamides
GB0025070D0 (en) Contrast agents
GB0009042D0 (en) Contrast agents
GB0019523D0 (en) Novel use
GB0007859D0 (en) Novel use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)